Quest Diagnostics (NYSE:DGX) Rating Increased to Buy at Stoc

StockNews.com upgraded shares of Quest Diagnostics (NYSE:DGX – Free Report) from a hold rating to a buy rating in a report issued on Friday. DGX has been the topic of several other reports. Citigroup upped their price target on Quest Diagnostics from $135.00 to $145.00 and gave the company a neutral rating in a research […]

Related Keywords

Tokio , Tokyo , Japan , United States , Catherinet Doherty , Karthik Kuppusamy , Nomura Asset Management Co , Citigroup , Jefferies Financial Group , Quest Diagnostics Incorporated , Quest Diagnostics , Securities Inc , Tokio Marine Asset Management Co , Ieq Capital , Lincoln National Corp , Securities Exchange Commission , Free Report , Financial Group , Get Free Report , Exchange Commission , Marine Asset Management , Asset Management , Diagnostics Incorporated , Quest Diagnostics Daily ,